June 2, 2025 By Dr. Dzung Tran, Australian College of Optometry (ACO) Repeated low-level red-light (RLRL) therapy is a promising strategy for...
May 1, 2025 By Mahmoud Haddara, BSc, OD The use of topical low-dose atropine to slow progression in myopic children is well...
January 2, 2025 By Leila Sara Eppenberger, MD, FEBO, FMH, MSc ETH Over the past few decades, the options for controlling myopia...
October 7, 2024 HAINAN ISLAND, China — At the 19th International Myopia Conference, HOYA Vision Care shared the eight-year results from its...
October 1, 2024 By Diba Rezazadeh, OD, AdvCertChVis(ACO) Topical low-dose atropine has become a popular myopia control treatment, and its ability to...
August 1, 2024 By Catherine Tay, BOptom, GradCertPublicHealth Environmental factors, genetic factors, and patient characteristics are important determinants that may help guide...
May 1, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE The management of juvenile-onset myopia is a critical public health issue,...
April 1, 2022 By Geetha Sravani, PhD Candidate, Brien Holden Vision Institute Myopia prevalence is high in many Asian countries. To delay...